Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 3/2001

01-09-2001 | Case Report

Corticotroph pituitary carcinoma: Case report and literature review

Authors: Dr. David J. Holthouse, MS, BS, Peter D. Robbins, MB, BS, FRCPA, Richard Kahler, MB, BS, FRACS, Neville Knuckey, MD, FRACS, Peter Pullan, MB, BS, FRACP, PhD

Published in: Endocrine Pathology | Issue 3/2001

Login to get access
Metadata
Title
Corticotroph pituitary carcinoma: Case report and literature review
Authors
Dr. David J. Holthouse, MS, BS
Peter D. Robbins, MB, BS, FRCPA
Richard Kahler, MB, BS, FRACS
Neville Knuckey, MD, FRACS
Peter Pullan, MB, BS, FRACP, PhD
Publication date
01-09-2001
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 3/2001
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1385/EP:12:3:329

Other articles of this Issue 3/2001

Endocrine Pathology 3/2001 Go to the issue

Editorial

Distinguishing benign from malignant thyroid lesions: Galectin 3 as the latest candidate

Case Report

Sporadic type composite pheochromocytoma with neuroblastoma: Clinicomorphologic, DNA content, and ret gene analysis

Clinical Research

Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas

Review

The MEN1 gene and associated diseases: An update

Basic Research

Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action

Clinical Research

CD markers in pituitary adenomas
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits